Financhill
Back

BioNTech SE 10K Form

Sell
46

BNTX
BioNTech SE

Last Price:
98.02
Seasonality Move:
23.17%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BNTX News And Ratings

See the #1 stock for the next 7 days that we like better than BNTX

BNTX Financial Statistics

Sales & Book Value

Annual Sales: $4.13B
Cash Flow: $-493.35M
Price / Cash Flow: 4.44
Annual Sales: $90.71
Price / Book: 1.1

Profitability

EPS (TTM): 0.48050
Net Income (TTM): $118.1M
Gross Margin: $3.49B
Return on Equity: 0.54%
Return on Assets: 0.49%

BioNTech SE Earnings Forecast

Key BioNTech SE Financial Ratios

  • The Gross Profit Margin over the past 7 years for BNTX is 84.29%.
  • The Selling, General & Administrative Expenses for BNTX have been equal to 14.60% of Gross Profit Margin.
  • The Research & Development expenses have been 46.69% of Revenue.
  • The Interest Expense is 0.17% of Operating Income.
  • The Net Earning history of BNTX is 24.36% of Total Revenues.
  • Per Share Earnings over the last 7 years have been positive in 3 years.

BioNTech SE Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: BNTX
CUSIP: 09075V
Website: biontech.de

Debt

Debt-to-Equity Ratio: 0.01
Current Ratio: 11.38
Quick Ratio: 10.95

Price-to-Earnings

Trailing P/E Ratio: 23.83
Forward P/E Ratio: 0

BNTX Technical Analysis vs Fundamental Analysis

Sell
46
BioNTech SE (BNTX) is a Sell

Is BioNTech SE a Buy or a Sell?

  • BioNTech SE stock is rated a Sell
    The current BioNTech SE [BNTX] share price is $98.80. The Score for BNTX is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.